Weld Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Weld Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,999	Closed	-$292K	–	175
2021 Q2	$292K	Buy	+2,999	New	+$267K	0.3%	148
2021 Q1	–	Sell	-4,784	Closed	-$458K	–	547
2020 Q4	$458K	Buy	+4,784	New	+$493K	0.18%	195
2020 Q1	–	Sell	-8,512	Closed	-$507K	–	709
2019 Q4	$507K	Buy	+8,512	New	+$525K	0.1%	344
2019 Q3	–	Sell	-25,642	Closed	-$1.65M	–	1002
2019 Q2	$1.65M	Buy	25,642 +20,756	+425%	+$1.34M	0.3%	77
2019 Q1	$310K	Buy	+4,886	New	+$257K	0.06%	506

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Weld Capital Management's TNDM Position: Q3 2021 in Review

Weld Capital Management sold out of Tandem Diabetes Care (TNDM) in Q3 2021, closing a stake of 2,999 shares — an estimated $292K sold.

Weld Capital Management first reported a position in TNDM in Q1 2019 and held it in 5 quarters. The position peaked at $1.65M in Q2 2019. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

Weld Capital Management reported no remaining Tandem Diabetes Care position as of Q3 2021 after selling out during the quarter.
Weld Capital Management sold 2,999 Tandem Diabetes Care shares in Q3 2021, an estimated $292K.
Weld Capital Management first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 5 quarters.
Weld Capital Management's Tandem Diabetes Care position peaked at $1.65M in Q2 2019.
337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on Weld Capital Management's 13F filing for Q3 2021.